文献速递心脑血管急症创伤与烧伤

急诊使用血浆脑生物标志物排除急性轻度创伤性脑损伤患者不必要的头部CT检查

Use of plasma-based brain biomarkers in the emergency department to rule out the need for unnecessary head CT imaging in acute mild traumatic brain injury patients.
PubMed 文献 · Am J Emerg Med · 2026-02-10
一句话结论在GCS 15的成人头部创伤患者中,TBI血浆标志物检测阴性可安全排除颅内损伤,潜在避免32.6%的CT检查并缩短诊断等待时间。

本研究为单中心观察性研究,纳入141例GCS 15的成人头部创伤患者,评估i-STAT® TBI Plasma检测盒(GFAP和UCH-L1)与CT结果的一致性。结果显示检测灵敏度100%、阴性预测值100%、特异性34.1%、阳性预测值6.3%。在生物标志物未升高的患者中,32.6%的CT检查可被避免,估计节省72.8小时;TBI生物标志物检测的诊断等待时间比单独等待CT结果少14.3小时(4.6%)。作者认为该检测盒具有优异的灵敏度和阴性预测值,可能安全排除不必要的CT检查并缩短诊断周转时间。

要点

  • 在141例GCS 15的成人头部创伤患者中,TBI血浆检测盒的灵敏度为100%,阴性预测值为100%,可识别CT上无颅内损伤的患者。
  • 生物标志物未升高的患者中,32.6%的CT检查本可避免,估计节省72.8小时。
  • TBI生物标志物检测的诊断等待时间比单独等待CT结果少14.3小时(4.6%)。
  • 检测盒特异性为34.1%,阳性预测值为6.3%;在<90岁和<65岁患者中特异性分别为34.6%和60.7%。
  • 作者认为该检测盒可能有效且安全地排除不必要的CT检查并缩短诊断周转时间,可能改善急诊流通量。

适用人群与场景

  • 在学术性急诊科就诊的成人头部创伤患者,格拉斯哥昏迷评分(GCS)为15分。

研究设计与关键结果

  • 单中心观察性研究,纳入141例成人头部创伤且GCS 15的患者,进行TBI生物标志物检测并与CT findings比较。
  • TBI血浆检测盒灵敏度100%、特异性34.1%、阳性预测值6.3%、阴性预测值100%。
  • 在<90岁和<65岁患者中,特异性分别为34.6%和60.7%。
  • 生物标志物未升高的患者中,32.6%的CT检查可被避免,估计节省72.8小时。
  • TBI生物标志物检测的诊断等待时间比单独等待CT结果少14.3小时(4.6%)。

证据类型、等级与局限

  • 证据类型:单中心观察性研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对于GCS 15的成人头部创伤患者,TBI血浆检测盒阴性(生物标志物未升高)可能安全排除颅内损伤,从而避免不必要的CT检查。
  • 使用该检测盒可能缩短诊断等待时间,改善急诊流通量。
  • 作者认为该检测盒可能有效且安全地排除不必要的CT检查并缩短诊断周转时间。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

INTRODUCTION: Computed tomography (CT) is the standard imaging modality for evaluating mild traumatic brain injury (mTBI) in emergency settings. However, most CT scans reveal no intracranial injury, raising concerns about unnecessary radiation exposure, healthcare costs, and diagnostic delays. Glial Fibrillary Acidic Protein (GFAP) and Ubiquitin C-terminal Hydrolase-L1 (UCH-L1) are promising biomarkers for mTBI assessment. The i-STAT® TBI Plasma cartridge enables rapid assessment of these biomarkers. This study evaluated clinical performance of the TBI Plasma cartridge, focusing on its potential to reduce unnecessary CT utilization and improve diagnostic turnaround times.

METHODS: A single-centre observational study was conducted in an academic emergency department. Adult patients presenting with head trauma and a GCS of 15 were enrolled. TBI biomarker testing was performed and compared to CT findings.

RESULTS: In 141 adult patients, the TBI plasma cartridge demonstrated 100% sensitivity, 34.1% specificity, 6.3% positive predictive value (PPV), and 100% negative predictive value (NPV). Among patients <90 and <65 years old, specificity was 34.6% and 60.7% respectively. In patients with non-elevated biomarkers, CT imaging could have been avoided in 32.6% of patients, saving an estimated 72.8 h. Diagnostic wait time associated with TBI biomarker testing was 14.3 h (4.6%) less than waiting for CT results alone.

CONCLUSION: The TBI plasma cartridge demonstrated excellent sensitivity and NPV in identifying patients without intracranial injury on CT. These findings suggest the potential for the TBI cartridge to efficiently and safely rule-out unnecessary CT imaging and reduce turnaround times for diagnostic test results, which may facilitate improved ED throughput.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Elkhodair S, Lalor J, Altaher M, et al. Use of plasma-based brain biomarkers in the emergency department to rule out the need for unnecessary head CT imaging in acute mild traumatic brain injury patients. Am J Emerg Med. 2026. PMID: 41707328. doi:10.1016/j.ajem.2026.02.013

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。